Australia markets open in 7 hours 58 minutes

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.20-0.15 (-2.80%)
As of 12:01PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 439.96M
Enterprise value 153.38M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.20
Price/book (mrq)1.26
Enterprise value/revenue 1.96
Enterprise value/EBITDA -0.94

Trading information

Stock price history

Beta (5Y monthly) 2.02
52-week change 3-33.29%
S&P500 52-week change 322.64%
52-week high 311.91
52-week low 35.11
50-day moving average 37.63
200-day moving average 38.35

Share statistics

Avg vol (3-month) 31.93M
Avg vol (10-day) 31.78M
Shares outstanding 582.23M
Implied shares outstanding 682.23M
Float 876.15M
% held by insiders 10.32%
% held by institutions 180.17%
Shares short (15 Apr 2024) 418.76M
Short ratio (15 Apr 2024) 49.51
Short % of float (15 Apr 2024) 428.92%
Short % of shares outstanding (15 Apr 2024) 422.81%
Shares short (prior month 15 Mar 2024) 413.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -196.12%
Operating margin (ttm)-39.90%

Management effectiveness

Return on assets (ttm)-20.87%
Return on equity (ttm)-43.17%

Income statement

Revenue (ttm)78.12M
Revenue per share (ttm)1.03
Quarterly revenue growth (yoy)818.70%
Gross profit (ttm)N/A
EBITDA -163.12M
Net income avi to common (ttm)-153.22M
Diluted EPS (ttm)-2.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)323.11M
Total cash per share (mrq)3.95
Total debt (mrq)36.54M
Total debt/equity (mrq)10.47%
Current ratio (mrq)5.39
Book value per share (mrq)4.27

Cash flow statement

Operating cash flow (ttm)-132.18M
Levered free cash flow (ttm)-87.81M